Global Cell Culture Industry is expected to achieve a valuation of over US$ 88.6 Billion by 2033, as per FMI’s forecast

The global cell culture industry demand has seen substantial growth and is projected to continue its upward trajectory, reaching an estimated valuation of around US$ 88.6 billion by 2033. This surge follows the industry’s impressive strides, from touching a valuation of US$ 25.4 billion in 2022 to reaching US$ 29.0 billion in 2023.

The forecasted compound annual growth rate (CAGR) of 11.8% between 2023 and 2033 underscores the remarkable expansion expected within the cell culture sector. This growth surge is attributed to the escalating demand for biopharmaceuticals, including critical vaccines and stem cells, alongside a significant uptick in research and development initiatives.

Request a Sample copy of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14318

The burgeoning need for biopharmaceuticals has fueled the expansion of the cell culture market. As the healthcare landscape continually evolves, the market has responded with increased production to meet the demand for these essential medical advancements.

The cell culture market growth is primarily driven by the increasing demand for biopharmaceutical products and the need for personalized medicine. As the prevalence of chronic diseases rises, pharmaceutical companies are investing heavily in cell culture technologies to develop novel therapies and improve existing ones. Additionally, the expansion of regenerative medicine and tissue engineering applications has further fueled the demand for advanced cell culture techniques.

Technological advancements and innovative solutions are also propelling the market forward. Researchers are continuously developing improved culture media, bioreactors, and 3D cell culture systems to mimic the in vivo conditions more accurately. These developments enhance cell viability, productivity, and overall efficiency, meeting the growing requirements of the biotechnology and pharmaceutical sectors.

Moreover, the increasing focus on stem cell research and the potential of cell-based therapies are contributing significantly to the market’s growth. Stem cells hold immense promise for treating various degenerative disorders and repairing damaged tissues. As a result, both academic and commercial organizations are investing extensively in stem cell research and its applications.

As per FMI, the key market drivers during the forecast period are:

• Acceleration in the pace of research and development activities aiding mass production of biopharmaceuticals
• Rising demand for advanced cell culture-based products
• Wide utility across pharmaceutical companies, research institutes, and food development
• Chronic diseases that warrant innovations in biopharmaceuticals
• Rising consumer demand for monoclonal antibodies (mAbs)

Get The Information You Need By Connecting With Our Analyst! https://www.futuremarketinsights.com/ask-question/rep-gb-14318

Cell Culture Application in Pharma & Health is Key to Market Growth:

At the moment, innovations are fueling market expansion. The need for sophisticated versions of cell culture products is growing as a result of significant investments made by various end-user groups in this area. Similar to how biosimilars have a favourable impact on market prospects, there is a rising need for innovative therapies.

All of these elements have worked together to carve out a specific application for cell culture in the pharmaceutical and healthcare industries. This is mostly brought on by the steady increase in cardiovascular, renal, and cancer disorders. Cell culture can open up lucrative opportunities for the pharmaceutical and healthcare industries to flourish as consumer demand for cutting-edge treatment solutions rises.

Key Takeaways from the Report:

• Between 2017 and 2022, the market recorded a CAGR of 13.5%, attaining a valuation of US$ 25.4 billion by 2022.
• During the forecast period, the United States market is projected to expand at a CAGR of 11.6% and reach a valuation of US$ 31.4 billion by 2033.
• Between 2023 and 2033, the United Kingdom market is expected to record a CAGR of 10.9%, to attain a valuation of US$ 3.7 billion by 2033.
• The consumables segment is projected to register a CAGR of 11.4% during the forecast period.
• The biopharmaceutical production segment is anticipated to witness a CAGR of 11.1% during the forecast period.

Unleashing the Potential of Personalization: Our Customization Report Guides You! https://www.futuremarketinsights.com/customization-available/rep-gb-14318

Key Market Developments:

• In January 2022, Cytiva (Danaher Corporation) announced its collaboration with Nucleus Biologics. This can be an important step towards developing custom culture media for cell as well as gene therapies.
• In February 2022, KromaTiD enhanced its services by venturing into cell and blood culture isolation, and processing, coupled with quality control services

Key Players:

• Danaher Corporation
• Thermo Fisher Scientific
• Becton
• Dickinson and Company
• Corning Incorporated
• Merck KgaA
• PromoCell GmbH
• Sartorius AG

Key Segments:

By Product:

• Consumables
  • Sera
  • Media
  • Reagents
  • Vessels
  • Accessories
• Equipment
  • Supporting Equipment
  • Bioreactors
  • Storage Equipment

By Application:

• Biopharmaceutical Production
  • Monoclonal antibodies
  • Vaccines production
  • Other therapeutic proteins
• Diagnostics
  • Drug Screening & Development
    • Tissue Engineering & Regenerative Medicine
  • Cell and gene therapy
• Others

By End User:

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Others

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• The Middle East and Africa (MEA)

Get Ahead with Detailed Market Intelligence: Discount Now to Access! https://www.futuremarketinsights.com/checkout/14318

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:

3D Cell Culture Market Size: The 3D cell culture market size is projected to be worth US$ 1.26 billion in 2023. The market is likely to reach US$ 3 billion by 2033. The market is further expected to surge at a CAGR of 9% during the forecast period 2023 to 2033.

Cell Culture Incubator Market Share: The global cell culture incubator market is expected to be valued at US$ 2,315.5 million in 2023, and is projected to reach US$ 4,305.1 million by 2033. A CAGR worth 6.4% is expected for the market during the 2023 to 2033 forecast period.

Cell Culture Media Market Growth: The cell culture media market size is projected to be valued at US$ 3.3 billion in 2023 and is expected to rise to US$ 6.4 billion by 2033. The sales of cell culture media are expected to expand at a significant CAGR of 7.0% during the forecast period.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube